Zobrazeno 1 - 10
of 99
pro vyhledávání: ''
Autor:
Cuizhen Liu, Xinping Ye, Yanfeng Jiang, Guangzhi Zhu, Jing Tang, Tao Peng, Jie Ma, Zhiming Zeng, Jie Zeng, Fuchao Ma, Jinfeng Qiu, Lihua Yang
Publikováno v:
Anti-Cancer Drugs. 32:1093-1098
This study was to explore the efficacy and safety of camrelizumab combined with apatinib in patients with advanced liver cancer. Moreover, the relationship between peripheral blood parameters and tumor response rate was also investigated. Patients wi
Autor:
Victor Traves, Esperanza Manrique-Silva, Celia Requena, Oscar M. Moreno-Arrones, Michael Gerbo, Josh Zegeer, Eduardo Nagore
Publikováno v:
Melanoma Research. 29:664-667
The aim of this study is to evaluate the relation between 25-hydroxyvitamin D levels at diagnosis and pathological characteristics in primary invasive melanoma. A cross-sectional study was designed based on a series of 204 consecutive patients diagno
Publikováno v:
Anti-Cancer Drugs. 30:179-185
In the pre-chemotherapy (CT) and post-CT settings of metastatic castration-resistant prostate cancer (mCRPC), abiraterone acetate plus prednisone (AAP) significantly extended median overall survival and radiographic progression-free survival (PFS) co
Autor:
Steven J. Cohen, Harry S. Cooper, Barbara Burtness, Jonathan D. Cheng, Adam C. Berger, Monica Davey, Igor Astsaturov, Patrick M Boland, Joshua E. Meyer, Anthony J. Olszanski, Walter J. Scott, Abraham Lebenthal, Tzahi Neuman
Publikováno v:
American Journal of Clinical Oncology. 40:393-398
Objectives: Preoperative chemotherapy and radiation for localized esophageal cancer produces cure rates near 30% when combined with surgical resection. Vandetanib, a small molecule receptor tyrosine kinase inhibitor of VEGFR-2, VEGFR-3, RET, and EGFR
Autor:
Hideki Ishikawa, Michihiro Mutoh, Toshiyuki Sakai, Tomiyo Nakamura, Atsuko Kawano, Nariaki Matsuura, Keiji Wakabayashi
Publikováno v:
European Journal of Cancer Prevention. 25:388-394
This prospective cohort study aimed to show that coffee prevents the recurrence of colorectal tumors (adenomas, precursors of colorectal cancer, and early-stage colorectal cancers) as well as colorectal cancer. The present study included 307 patients
Autor:
Elisabeth Odin, Bengt Gustavsson, Clemens C. Stoffregen, Göran Kurlberg, Göran Carlsson, Maria T. Tångefjord, H. Bjorkqvist
Publikováno v:
Anti-Cancer Drugs
The objectives of this single-center, open-label, phase II study were to evaluate (a) the feasibility and safety of neoadjuvant administration of pemetrexed with oral folic acid and vitamin B12 (FA/B12) in newly diagnosed patients with resectable rec
Autor:
Salvatora Tindara Miano, Giandomenico Roviello, Vincenzo Bianco, Edoardo Francini, Roberto Petrioli, Letizia Laera, Anna Ida Fiaschi
Publikováno v:
Anti-Cancer Drugs. 26:878-883
The primary objective of this study was to determine the activity and safety of carboplatin, methotrexate, vinblastine, and epirubicin (the M-VECa regimen) in patients with advanced bladder cancer after failure of at least one chemotherapy line. Trea
Autor:
Michio Imamura, Wataru Yasui, Masashi Fujita, Masami Yamauchi, Peiyi Zhang, Hidewaki Nakagawa, Masataka Tsuge, Akira Ishikawa, Haruna Hatooka, Daiki Miki, Kenichiro Kodama, Kazuaki Chayama, Eisuke Murakami, Clair Nelson Hayes, Tomokazu Kawaoka, Takashi Nakahara, Yuji Teraoka, Hiroshi Aikata, Kei Morio, Hatsue Fujino, Shinsuke Uchikawa, Atsushi Ono, Akira Hiramatsu
Publikováno v:
Clinical and Translational Gastroenterology
Liver cancer accounts for the sixth highest cancer incidence and is the fourth leading cause of cancer death worldwide (1). Developing molecular-targeted and biomarker-enriched therapeutic strategies against hepatocellular carcinoma (HCC), which is t
Autor:
Anthony J. Olszanski, Olivier Rixe, Olugbenga Olowokure, Séverine Doroumian, John C. Morris, Jian Y. Yin, Roger B. Cohen, Liji Shen, Igor Puzanov, Patricia LoRusso
Publikováno v:
Anti-Cancer Drugs
Supplemental Digital Content is available in the text.
Taxane–gemcitabine combinations have demonstrated antitumor activity. This phase I study (NCT01001221) aimed to determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT
Taxane–gemcitabine combinations have demonstrated antitumor activity. This phase I study (NCT01001221) aimed to determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT
Prognostic value of telomere function in gastric cancers with and without microsatellite instability
Autor:
Carmen de Juan, Irene Pascua, Jacqueline Head, Pilar Iniesta, Andrés Sánchez-Pernaute, Tamara Fernández-Marcelo, Antonio-José Torres-García
Publikováno v:
European Journal of Gastroenterology & Hepatology. 27:162-169
Objective To identify molecular markers that may be useful in the selection of gastric cancer patients with different prognoses, we investigated telomere function in gastric cancers with and without microsatellite instability (MSI). Materials and met